Binder jet 3D printing composite bilayer tablet of extended-release printing technology in the study
10.16438/j.0513-4870.2023-0166
- VernacularTitle:黏结剂喷射型3D打印复方双层片中的缓释打印工艺研究
- Author:
Wen-lan GUO
1
;
Shan-shan WANG
2
;
Xiao-xuan HONG
2
;
Xiao-lu HAN
2
;
Hui ZHANG
2
;
Nan LIU
2
;
Zeng-ming WANG
2
;
Chun-di HU
3
;
Ai-ping ZHENG
2
Author Information
1. Pharmacy School, Hubei University of Science and Technology, Xianning 437100, China; Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China
2. Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China
3. Pharmacy School, Hubei University of Science and Technology, Xianning 437100, China
- Publication Type:Research Article
- Keywords:
binder jet 3D printing;
acetaminophen;
moxifloxacin hydrochloride;
full factor experimental design;
process optimization;
release model fitting
- From:
Acta Pharmaceutica Sinica
2023;58(10):3108-3115
- CountryChina
- Language:Chinese
-
Abstract:
Based on the dual needs of analgesia and anti-inflammation in trauma treatment, this study uses acetaminophen and moxifloxacin hydrochloride as active pharmaceutical ingredients and develops a composite bilayer tablet with a dual-phase drug release system by using binder jet 3D printing technology. Due to the complexity of the 3D printing process, there is an interaction between the various parameters. Through the optimization of the process, the relationship between the key process parameters can be determined more intuitively. In this study, the process of extended-release tablets was optimized to maintain the mechanical properties of the tablets while realizing the regulation of release. The full-factor experimental design of three central points 23 was used to analyze the factors that significantly affect the quality attributes of extended-release tablets and the interaction between factors. The optimal extended-release process parameters were obtained by the response optimizer: the inkjet quantity of the printing ink was 10 (about 13.8 pL), the powder thickness was 180 μm, and the running speed was 360 mm·s-1. The in vitro of release of 3D printed composite bilayer tablets showed that the in vitro of release of 3D printed tablets and commercially available tablets conformed to the Ritger-Peppas release model. The results of porosity showed that the immediate-release layer of the preparation has many pores and large pore size, and the dissolution of the immediate release layer within 15 min was greater than 85%. The internal pore size of the extended release layer is large, but it can still release slowly for up to 8 h, the mechanism may be related to the extended release of HPMC gelation. On the basis of verifying the rationality of the design goal of 3D printed composite bilayer tablets, this study also provides a theoretical basis for the preparation of 3D printing complex preparations.
